Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Finished Goods (2016 - 2019)

Tandem Diabetes Care's Finished Goods history spans 6 years, with the latest figure at $9.7 million for Q1 2019.

  • For Q1 2019, Finished Goods fell 21.48% year-over-year to $9.7 million; the TTM value through Mar 2019 reached $9.7 million, down 21.48%, while the annual FY2018 figure was $10.6 million, 17.81% down from the prior year.
  • Finished Goods reached $9.7 million in Q1 2019 per TNDM's latest filing, down from $10.6 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $14.4 million in Q3 2017 to a low of $2.9 million in Q2 2015.
  • Average Finished Goods over 5 years is $8.5 million, with a median of $9.1 million recorded in 2016.
  • Peak YoY movement for Finished Goods: soared 145.5% in 2016, then dropped 21.48% in 2019.
  • A 5-year view of Finished Goods shows it stood at $3.5 million in 2015, then skyrocketed by 109.57% to $7.4 million in 2016, then surged by 73.1% to $12.9 million in 2017, then dropped by 17.81% to $10.6 million in 2018, then decreased by 8.36% to $9.7 million in 2019.
  • Per Business Quant, the three most recent readings for TNDM's Finished Goods are $9.7 million (Q1 2019), $10.6 million (Q4 2018), and $11.3 million (Q3 2018).